Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary Foster

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Ovarian Research|November 5, 2014
Notch signaling in serous ovarian cancerJolijn W Groeneweg, Rosemary Foster, Whitfield B Growdon, et al.
Cancers|November 2, 2019
The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem CellsChiara Bellio, Celeste DiGloria, David R Spriggs, et al.
Gynecologic Oncology|March 29, 2016
Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutationSilvia F Hernandez, Sarah Chisholm, Darrell Borger, et al.
Molecular Pharmacology|August 7, 2007
8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cellsZhenfeng Duan, James Bradner, Edward Greenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocationZhenfeng Duan, James E Bradner, Edward Greenberg, et al.
Molecular Cancer Research : MCR|November 8, 2018
PARP Inhibition Induces Enrichment of DNA Repair-Proficient CD133 and CD117 Positive Ovarian Cancer Stem CellsChiara Bellio, Celeste DiGloria, Rosemary Foster, et al.
American Journal of Medical Genetics. Part A|February 27, 2010
Monozygotic twins discordant for neurofibromatosis 1Lee Kaplan, Rosemary Foster, Yiping Shen, et al.
Reproductive Biology and Endocrinology : RB&E|May 12, 2018
MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyomaEden R Cardozo, Rosemary Foster, Anatte E Karmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancerZhenfeng Duan, Rosemary Foster, Debra A Bell, et al.
Frontiers in Oncology|July 30, 2014
Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growthJolijn W Groeneweg, Celeste M DiGloria, Jing Yuan, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Ovarian Research|November 5, 2014
Notch signaling in serous ovarian cancerJolijn W Groeneweg, Rosemary Foster, Whitfield B Growdon, et al.
Cancers|November 2, 2019
The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem CellsChiara Bellio, Celeste DiGloria, David R Spriggs, et al.
Gynecologic Oncology|March 29, 2016
Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutationSilvia F Hernandez, Sarah Chisholm, Darrell Borger, et al.
Molecular Pharmacology|August 7, 2007
8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cellsZhenfeng Duan, James Bradner, Edward Greenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocationZhenfeng Duan, James E Bradner, Edward Greenberg, et al.
Molecular Cancer Research : MCR|November 8, 2018
PARP Inhibition Induces Enrichment of DNA Repair-Proficient CD133 and CD117 Positive Ovarian Cancer Stem CellsChiara Bellio, Celeste DiGloria, Rosemary Foster, et al.
American Journal of Medical Genetics. Part A|February 27, 2010
Monozygotic twins discordant for neurofibromatosis 1Lee Kaplan, Rosemary Foster, Yiping Shen, et al.
Reproductive Biology and Endocrinology : RB&E|May 12, 2018
MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyomaEden R Cardozo, Rosemary Foster, Anatte E Karmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancerZhenfeng Duan, Rosemary Foster, Debra A Bell, et al.
Frontiers in Oncology|July 30, 2014
Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growthJolijn W Groeneweg, Celeste M DiGloria, Jing Yuan, et al.
Pageof 4